iCAD to Report Second Quarter 2022 Financial Results on August 10, 2022
Rhea-AI Summary
iCAD, Inc. (NASDAQ: ICAD) will announce its second-quarter financial results on August 10, 2022, after market closure. The results will be followed by a conference call at 4:30 PM ET. This announcement highlights iCAD's ongoing commitment to transparency and investor engagement as it continues to provide innovative solutions in cancer detection and therapy.
Positive
- None.
Negative
- None.
News Market Reaction – ICAD
In the trading session that priced this news, ICAD gained 1.30%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NASHUA, N.H., July 27, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the second quarter ended June 30, 2022, after the market close, and host a conference call at 4:30 PM Eastern Time on August 10, 2022.
August 10, 2022 at 4:30 PM ET
Domestic: 888-506-0062
International: 973-528-0011
Conference ID: 718241
Webcast: https://www.webcaster4.com/Webcast/Page/2879/46166
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com
Investor Inquiries:
iCAD Investor Relations
ir@icadmed.com
